Citations

Showing 10 of 108162 citations.

Clinical Characteristics, Outcomes, Disposition, and Acute Care of Children and Adolescents Treated for Acetaminophen Toxicity
Shekunov, Julia , Lewis, Charles P. , Voort, Jennifer L. Vande , Bostwick, John , Romanowicz, Magdalena , Vande Voort, Jennifer L., Bostwick, J Michael

Mayo Clinic

Psychiatric Services | April 23, 2021 | Volume: 72 | Issue: 7 | Pages: 758-765

10.1176/appi.ps.202000081 | PMID 33887959 Get It

Training of Pediatric Critical Care Providers in Developing Countries in Evidence Based Medicine Utilizing Remote Simulation Sessions
Padhya, Dipti , Alsawas, Mouaz , Murthy, Srinivas , Arteaga, Grace M. , Alsawas, Mouaz , Tripathi, Sandeep , Kashyap, Rahul , Dong, Yue

Mayo Clinic

Global Pediatric Health | April 23, 2021 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/2333794x211007473 | PMID 33997121 Get It

Background. Remote simulation training provides a unique opportunity to captivate providers despite language, distance, and cultural barriers. Previously we developed a novel electronic decision support and rounding tool, the Checklist for Early Recognition and Treatment of Acute Illness in Pediatrics (CERTAINp). This study was conducted to determine the feasibility and impact of remote simulation training of international PICU providers using CERTAINp. Methods. We conducted train-the-trainer sessions in 7 hospitals based in 5 countries (China, Congo, Croatia, India, and Turkey) between 11/2015 and 11/2016. Providers first took part in a base line simulation session to assess their clinical performance. They had structured hands-on training using CERTAINp, which was done remotely using video conference with recording capabilities. Performance in PICU “admission” and “rounding” scenarios was assessed by their adherence to standard of care guidelines using CERTAINp. After this training, the providers were re-evaluated for performance using a validated instrument by 2 independent trained reviewers. Results. A total of 7 hospitals completed both baseline and post simulation sessions. We observed improved critical task (total 14) completion in the admission scenarios where pre training task completion was 8.2 ± 2.6, while after remote training was 11.2 ± 1.8, P = .01. In rounding scenarios, compliance to standard of care guidelines improved overall from 45% to 95% ( P < .01). Conclusion. We observed an improvement in compliance for measures determined as best practice guidelines in simulation rounding and overall improvement in critical tasks for simulated admission cases after remote training.
Predicting Gag, Discomfort, and Laryngeal Visualization in Patients Undergoing Flexible Laryngoscopy with Stroboscopy
Kiessling, Patrick , Bayan, Semirra L. , Lohse, Christine M. , Orbelo, Diana M. , Bayan, Semirra, Lohse, Christine, Orbelo, Diana, Bayan, Semirra , Orbelo, Diana

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | April 23, 2021 | Volume: 131 | Issue: 2 | Pages: 164-172

10.1177/00034894211011453 | PMID 33890497 Get It

Objective: To investigate potential associations between the Predictive Gagging Survey (PGS) with patient experience of gag and discomfort as well as provider perception of patient gag and level of laryngeal visualization during flexible laryngoscopy with stroboscopy (FL-S). Methods: A total of 53 adult patients undergoing FL-S were recruited for this prospective non-controlled study. PGS was completed before FL-S. Patients rated perceived level of gag and discomfort on a 10-point severity scale after FL-S. Additionally, providers completed a Gagging Severity Index (GSI) reflecting their impression of patient gag and level of laryngeal visualization following FL-S. Spearman rank correlation coefficients were used to assess associations. Results: There was a positive association with PGS score and patient perception of gagging (0.34; P = .013) and patient perception of discomfort (0.38; P = .005). No significant association was found between PGS score and provider GSI (−0.12; P = .39) or level of laryngeal visualization (0.15; P = .29). A negative association was found between level of laryngeal visualization and patient perception of gagging (−0.34; P = .012) and discomfort (−0.44; P = .001). No significant differences were found between current and former smokers compared to never smokers for GSI or patient-perceived gag or discomfort. Conclusions: While not predictive of GSI or level of laryngeal visualization, the PGS was found to be a useful tool in predicting patient experience of gagging and discomfort during FL-S, further reinforcing the subjective experience of this procedure. Use of the PGS may be helpful in identifying specific candidates who may struggle with subjective discomfort or gagging during FL-S for future studies considering interventions to manage and meaningfully decrease discomfort. Having such an instrument is important given the low number of individuals who struggle with discomfort during the exam.
Musculoskeletal ultrasound as a diagnostic tool for eosinophilic fasciitis and correlation with magnetic resonance imaging findings
Narula, Neha, Abril, Andy , Calamia, Kenneth , Berianu, Florentina , Narula, Neha G, Calamia, Kenneth T

Mayo Clinic

International Journal of Rheumatic Diseases | April 23, 2021 | Volume: 24 | Issue: 5 | Pages: 721-723

10.1111/1756-185x.14099 | PMID 33890386 Get It

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
Swift, Melanie D. , Breeher, Laura E. , Tande, Aaron J. , Tommaso, Christopher P., Hainy, Caitlin , Chu, Haitao , Berbari, Elie F. , Virk, Abinash , Hainy, Caitlin M, Tande, Aaron , Swift, Melanie D , Chu, Haitao , Breeher, Laura , Hainy, Caitlin M. , Murad, M. Hassan

Mayo Clinic

Clinical Infectious Diseases | April 23, 2021 | Volume: 73 | Issue: 6 | Pages: e1376-e1379

10.1093/cid/ciab361 | PMID 33900384 Get It

Abstract In a large cohort of United States healthcare personnel without prior coronavirus disease 2019 (COVID-19) infection, 94 382 doses of messenger RNA (mRNA) COVID-19 vaccine were administered to 49 220 individuals. The adjusted vaccine effectiveness following 2 doses of each of the 2 available brands of mRNA vaccine exceeded 96%.
Outcomes of Living Kidney Donor Candidate Evaluations in the Living Donor Collective Pilot Registry
Kasiske, Bertram L. , Ahn, Yoon Son, Conboy, Michael, Dew, Mary Amanda , Folken, Christian, Levan, Macey L. , Lentine, Krista L. , Matas, Arthur J. , Newell, Kenneth A. , Massie, Allan B. , Musgrove, Donald, Taler, Sandra J. , Wang, Jeffrey , Israni, Ajay K. , Rudow, Dianne LaPointe , Snyder, Jon J. , Waterman, Amy D

Mayo Clinic

Transplantation Direct | April 23, 2021 | Volume: 7 | Issue: 5 | Pages: e689

10.1097/txd.0000000000001143 | PMID 33912656 Get It

Background. Gaps in our knowledge of long-term outcomes affect decision making for potential living kidney donors. Methods. The Scientific Registry of Transplant Recipients was asked to determine the feasibility of a candidate registry. Results. Ten living kidney donor programs evaluated 2107 consecutive kidney donor candidates; 2099 of 2107 (99.6%) completed evaluations, 1578 of 2099 (75.2%) had a decision, and 790 of 1578 (50.1%) were approved to donate as of March 12, 2020. By logistic regression, candidates most likely to be approved were married or had attended college or technical school; those least likely to be approved had ≥1 of the following characteristics: Black race, history of cigarette smoking, and higher blood pressure, higher triglycerides, or higher urine albumin-to-creatinine ratios. Reasons for 617 candidates not being approved included medical issues other than chronic kidney disease risk (25.3%), chronic kidney disease risk (18.5%), candidate withdrawal (15.2%), recipient reason (13.6%), anatomical risk to the recipient (10.3%), noneconomic psychosocial (10.3%), economic (0.5%), and other reasons (6.4%). Conclusions. These results suggest that a comprehensive living donor registry is both feasible and necessary to assess long-term outcomes that may inform decision making for future living donor candidates. There may be socioeconomic barriers to donation that require more granular identification so that active measures can address inequities. Some candidates who did not donate may be suitable controls for discerning the appropriateness of acceptance decisions and the long-term outcomes attributable to donation. We anticipate that these issues will be better identified with modifications to the data collection and expansion of the registry to all centers over the next several years.
Intralesional Bleomycin Injection in Management of Localized Venous Problems in Children with Klippel-Trenaunay Syndrome
Hudson, Donald A. , Mohan, Anita T. , Lelala, Ngoato B.

Mayo Clinic

Plastic & Reconstructive Surgery | April 23, 2021 | Volume: 147 | Issue: 5 | Pages: 918e-919e

10.1097/prs.0000000000007815 | PMID 33885399 Get It

Effect of Reduction Mammoplasty on Pulmonary Function Tests
Guliyeva, Günel , Cheung, Joseph , Huayllani, María T. , Broer, P. Niclas, Forte, Antonio J. , Cheung, Joseph Y, Forte, Antonio Jorge , Cheung, Joseph , Ávila, Francisco R. , Boczar, Daniel

Mayo Clinic

Annals of Plastic Surgery | April 23, 2021 | Volume: 87 | Issue: 6 | Pages: 694-698

10.1097/sap.0000000000002834 | PMID 33883434 Get It

Abstract In patients with breast hypertrophy, excessive breast weight applies pressure on the thorax, which may disrupt the normal breathing. The purpose of this study is to evaluate the impact of the breast hypertrophy and reduction mammoplasty on respiratory function. A comprehensive search of 3 databases, PubMed, Ovid, and Scopus databases, was performed. “Mammoplasty” and “respiration or pulmonary function tests” were the keywords used to search for relevant articles. Ten studies involving 280 patients with breast hypertrophy were included in the final review. Seven articles demonstrated an increase in at least 1 pulmonary function test value after the surgery. This systematic review revealed that, preoperatively, pulmonary function test values of the patients are usually in the normal range. Nonetheless, reduction mammoplasty still improves lung function parameters. Additionally, patients with respiratory complaints felt improvement in their symptoms after the surgery. However, future studies are needed, as heterogeneity among studies was observed.
The thrombin receptor modulates astroglia‐neuron trophic coupling and neural repair after spinal cord injury
Kim, Ha Neui , Triplet, Erin M. , Bouchal, Samantha M. , Kleppe, Laurel S., Simon, Whitney L., Yoon, Hyesook, Scarisbrick, Isobel A. , Radulovic, Maja, Scarisbrick, Isobel A , Bouchal, Samantha M , Radulovic, Maja

Mayo Clinic

Glia | April 22, 2021 | Volume: 69 | Issue: 9 | Pages: 2111-2132

10.1002/glia.24012 | PMID 33887067 Get It

AbstractExcessive activation of the thrombin receptor, protease activated receptor 1 (PAR1) is implicated in diverse neuropathologies from neurodegenerative conditions to neurotrauma. PAR1 knockout mice show improved outcomes after experimental spinal cord injury (SCI), however information regarding the underpinning cellular and molecular mechanisms is lacking. Here we demonstrate that genetic blockade of PAR1 in female mice results in improvements in sensorimotor co‐ordination after thoracic spinal cord lateral compression injury. We document improved neuron preservation with increases in Synapsin‐1 presynaptic proteins and GAP43, a growth cone marker, after a 30 days recovery period. These improvements were coupled to signs of enhanced myelin resiliency and repair, including increases in the number of mature oligodendrocytes, their progenitors and the abundance of myelin basic protein. These significant increases in substrates for neural recovery were accompanied by reduced astrocyte (Serp1) and microglial/monocyte (CD68 and iNOS) pro‐inflammatory markers, with coordinate increases in astrocyte (S100A10 and Emp1) and microglial (Arg1) markers reflective of pro‐repair activities. Complementary astrocyte‐neuron co‐culture bioassays suggest astrocytes with PAR1 loss‐of‐function promote both neuron survival and neurite outgrowth. Additionally, the pro‐neurite outgrowth effects of switching off astrocyte PAR1 were blocked by inhibiting TrkB, the high affinity receptor for brain derived neurotrophic factor. Altogether, these studies demonstrate unique modulatory roles for PAR1 in regulating glial‐neuron interactions, including the capacity for neurotrophic factor signaling, and underscore its position at neurobiological intersections critical for the response of the CNS to injury and the capacity for regenerative repair and restoration of function.